A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Organon & Co. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 92 shares of OGN stock, worth $1,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92
Previous 92 -0.0%
Holding current value
$1,408
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $881 - $1,203
-64 Reduced 41.03%
92 $1,000
Q3 2023

Nov 09, 2023

BUY
$16.59 - $23.77 $1,526 - $2,186
92 Added 143.75%
156 $2,000
Q2 2023

Aug 08, 2023

SELL
$19.27 - $24.63 $3,121 - $3,990
-162 Reduced 71.68%
64 $1,000
Q4 2022

Mar 02, 2023

SELL
$23.31 - $28.61 $233 - $286
-10 Reduced 4.24%
226 $6,000
Q3 2022

Nov 15, 2022

BUY
$23.4 - $34.25 $5,288 - $7,740
226 Added 2260.0%
236 $6,000
Q1 2022

Jun 17, 2022

BUY
$30.45 - $39.36 $304 - $393
10 New
10 $0

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.